Clinical Psychopharmacology

Description:  This course overviews aspects of brain and nerve anatomy that are relevant to understanding the effects of both psychotropic medications, and controlled and illicit substances. A discussion of the processes of absorption, distribution, metabolization, and elimination of drugs in the body will illuminate why withdrawal, tolerance, and other physiological phenomenon occur with psychoactive substance use disorders (PSUDs).  There is a discussion several classifications of neurotransmitters, what is known or believed about their action in the nervous system, a discussion of the classification of psychotropic medications; the generic/brand medications in these classifications, significant side effects, and indications.  The last module will cover the classes of controlled and illicit substances.  Illustrations are used to show the action of these substances in the synapse to help participants understand intoxication, dependence, overdose, and tolerance. The US DEA schedule of controlled substances and drug trafficking penalties is provided.

CE Credits:  6

CE Broker #:  20-10033

Methods: Pre-test, study guide, posttest and evaluation, internet sources via URLs, Q&A by email.

Content Areas:  Psychopharmacology, Addictions, Social and cultural foundations, Applications to practice, Clinical evaluation and assessment, Psychotropic medications, Co-existing conditions, Dual disorders.

Purpose:  Learners will be better able to understand the physiological effects of psychotropic medications and be equipped to educate clients and inform physicians and other intervention specialists regarding patient symptoms and reactions to medications.

Target Audience: Social workers, marriage and family therapists, licensed professional counselors, mental health counselors, nurses, employee assistance professionals, addiction professionals, behavioral health technicians, and other allied professionals who may work with these populations.